Domů › Metastatický karcinom › Ohio › Cincinnati
Klinické studie Metastatický karcinom v Cincinnati, OH
20 studií pro Metastatický karcinom hledá účastníky v lokalitách v Cincinnati a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Probíhá náborFáze 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · Vzdálenost 15 mi
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · Vzdálenost 15 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- a dalších 1
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Probíhá náborFáze 3
- Research Site, Cincinnati
- Research Site, Cincinnati
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Probíhá náborFáze 3
- University of Cincinnati Medical Center, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Probíhá náborFáze 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · Vzdálenost 8 mi
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- University of Cincinnati Medical Center, Cincinnati
- Oncology Hematology Care Inc, Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Probíhá náborFáze 3
- Research Site, Edgewood · Vzdálenost 8 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- USO - Oncology Hematology Care, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Probíhá náborFáze 2
- St. Elizabeth Healthcare, Edgewood · Vzdálenost 8 mi
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Probíhá náborFáze 1
- University of Cincinnati Medical Center (UCMC), Cincinnati
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Oncology Hematology Care Primary, Cincinnati
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Probíhá náborFáze 3
- Research Site, Cincinnati
A Study of PYX-201 in Advanced Solid Tumors
Probíhá náborFáze 1
- University of Cincinnati Medical Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- Christ Hospital Cancer Center, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Probíhá náborFáze 2
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Probíhá náborFáze 1
- The Christ Hospital Cancer Center, Cincinnati
Studie Metastatický karcinom v jiných městech
- Houston, TX104 studií
- New York City, NY93 studií
- Nashville, TN70 studií
- Boston, MA63 studií
- Los Angeles, CA57 studií
- St. Louis, MO54 studií
- Arlington, VA53 studií
- Philadelphia, PA46 studií
- Chicago, IL45 studií
- San Antonio, TX44 studií
- Washington, DC43 studií
- Dallas, TX42 studií
Další studie v Cincinnati
- Nemalobuněčný plicní karcinom35 studií
- Rakovina (všechny typy)27 studií
- Rakovina prsu25 studií
- Srdeční selhání24 studií
- Kolorektální karcinom21 studií
- Akutní myeloidní leukemie20 studií
- Rakovina vaječníků19 studií
- Rakovina plic19 studií
- Obesity19 studií
- Rakovina prostaty18 studií
- Mnohočetný myelom17 studií
- Melanom17 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.